INFUTREL Trademark

Trademark Overview

On Tuesday, November 15, 2022, a trademark application was filed for INFUTREL with the United States Patent and Trademark Office. The USPTO has given the INFUTREL trademark a serial number of 97677779. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 10, 2024. This trademark is owned by Sandoz Canada Inc.. The INFUTREL trademark is filed in the Pharmaceutical Products category with the following description:

Trace elements for injection, namely, dietetic infusions for medical use containing copper, chromium, zinc, selenium, manganese, iron, iodine, fluoride and molybdenum for parenteral infusion
infutrel

General Information

Serial Number97677779
Word MarkINFUTREL
Filing DateTuesday, November 15, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2024

Trademark Statements

Goods and ServicesTrace elements for injection, namely, dietetic infusions for medical use containing copper, chromium, zinc, selenium, manganese, iron, iodine, fluoride and molybdenum for parenteral infusion
Translation of Words in MarkThe wording INFUTREL has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSandoz Canada Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoucherville, Quebec J4B7K8
CA
Party NameSandoz Canada Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoucherville, Quebec J4B7K8
CA

Trademark Events

Event DateEvent Description
Tuesday, August 29, 2023NON-FINAL ACTION WRITTEN
Friday, November 18, 2022NEW APPLICATION ENTERED
Friday, November 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 29, 2023ASSIGNED TO EXAMINER
Tuesday, August 29, 2023NON-FINAL ACTION E-MAILED
Tuesday, August 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 17, 2023FINAL REFUSAL WRITTEN
Friday, November 17, 2023FINAL REFUSAL E-MAILED
Friday, November 17, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 14, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, May 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 1, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, February 14, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, May 29, 2024NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Wednesday, May 29, 2024ACTION CONTINUING A FINAL - COMPLETED
Wednesday, May 29, 2024CONTINUATION OF FINAL REFUSAL E-MAILED
Friday, June 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 7, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, June 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 26, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

infutrel iron manganese selenium iodine fluoride infusion parenteral molybdenum zinc chromium